Skip to content
Jabez Biosciences
  • About
  • Science
  • Pipeline
  • News
  • Contact
  • Invest
  • Our Clinical Trials

For Patients: Our Phase I trial is currently enrolling!

Learn More
Jabez BiosciencesJabez Biosciences
  • About
  • Science
  • Pipeline
  • News
  • Contact
  • Invest
  • Our Clinical Trials
Jabez BiosciencesJabez Biosciences

Category Press Releases

  • Press Releases

Multi-institutional team awarded NCI grant to open novel AML trial

  • Dave Mehalick
  • June 23, 2025
  • Press Releases

Jabez Biosciences, Inc. Announced Phase 1 Clinical Trial of JBZ-001 at AACR 2025

Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma

  • Shane Hackett
  • May 9, 2025
  • Press Releases

Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001 

  • Shane Hackett
  • April 3, 2025
  • About
  • Science
  • Pipeline
  • News
  • Contact
  • Invest
  • Our Clinical Trials

Copyright © 2025 Jabez Biosciences - by Oncoleader Scientific Communications